Open AccessThe use of Ophthalmic Dorzolamide in Al-Kharj
Author(s) -
Nehad J. Ahmad,
Mohammad Ayman Salkini
Publication year - 2021
Publication title -
journal of pharmaceutical research international
Language(s) - English
Resource type - Journals
ISSN - 2456-9119
DOI - 10.9734/jpri/2021/v33i60b34641
Subject(s) - dorzolamide , medical prescription , medicine , ophthalmology , intraocular pressure , optometry , anesthesia , pharmacology , timolol
Aim: The present study was to explore the use of ophthalmic dorzolamide in Al-Kharj.
Methodology: This is a retrospective study that includes reviewing the electronic prescriptions of ophthalmic dorzolamide among outpatients in a public hospital in Alkharj.
Results: Only 24 patients received ophthalmic dorzolamide during the study. The age of more than 54% of the patients was more than 59 years and more than 54% of them were males. More than 54% of the patients received ophthalmic dorzolamide for 2 months and 37.50% of them received ophthalmic dorzolamide for 3 months. All of the prescriptions were prescribed by ophthalmology department and more than 95% of the prescriptions were written by residents.
Conclusion: The present study showed that ophthalmic dorzolamide was uncommonly prescribed in Al-Kharj. Further studies are needed to explore the frequency of using dorzolamide in other settings and to explore the frequency of using other eye drops that are used to decrease intraocular pressure.